WO2000012760A3 - Marqueurs de reaction toxicologique - Google Patents

Marqueurs de reaction toxicologique Download PDF

Info

Publication number
WO2000012760A3
WO2000012760A3 PCT/US1999/019768 US9919768W WO0012760A3 WO 2000012760 A3 WO2000012760 A3 WO 2000012760A3 US 9919768 W US9919768 W US 9919768W WO 0012760 A3 WO0012760 A3 WO 0012760A3
Authority
WO
WIPO (PCT)
Prior art keywords
response markers
toxicological response
composition
relates
present
Prior art date
Application number
PCT/US1999/019768
Other languages
English (en)
Other versions
WO2000012760A2 (fr
Inventor
Mary Jane Cunningham
Gary B Zweiger
Scott R Panzer
Jeffrey J Seilhamer
Original Assignee
Incyte Pharma Inc
Mary Jane Cunningham
Gary B Zweiger
Scott R Panzer
Jeffrey J Seilhamer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/141,825 external-priority patent/US6403778B1/en
Priority claimed from US09/172,108 external-priority patent/US6160104A/en
Priority claimed from US09/172,711 external-priority patent/US6160105A/en
Application filed by Incyte Pharma Inc, Mary Jane Cunningham, Gary B Zweiger, Scott R Panzer, Jeffrey J Seilhamer filed Critical Incyte Pharma Inc
Priority to AU60222/99A priority Critical patent/AU6022299A/en
Priority to CA002340589A priority patent/CA2340589A1/fr
Priority to JP2000567743A priority patent/JP2002523112A/ja
Priority to EP99968250A priority patent/EP1108067A2/fr
Publication of WO2000012760A2 publication Critical patent/WO2000012760A2/fr
Publication of WO2000012760A3 publication Critical patent/WO2000012760A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection

Abstract

L'invention concerne une composition comprenant plusieurs molécules d'acides nucléiques. La composition peut être utilisée sous la forme d'éléments hybridables d'un jeu ordonné de microéchantillons. La présente invention concerne aussi des procédés pour cribler des composés et des agents thérapeutiques à la recherche de réactions métaboliques indiquant la présence d'un composé toxique.
PCT/US1999/019768 1998-08-28 1999-08-27 Marqueurs de reaction toxicologique WO2000012760A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU60222/99A AU6022299A (en) 1998-08-28 1999-08-27 Toxicological response markers
CA002340589A CA2340589A1 (fr) 1998-08-28 1999-08-27 Marqueurs de reaction toxicologique
JP2000567743A JP2002523112A (ja) 1998-08-28 1999-08-27 毒物学的反応マーカー
EP99968250A EP1108067A2 (fr) 1998-08-28 1999-08-27 Marqueurs de reaction toxicologique

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/141,825 US6403778B1 (en) 1998-05-04 1998-08-28 Toxicological response markers
US09/172,108 US6160104A (en) 1998-10-13 1998-10-13 Markers for peroxisomal proliferators
US09/172,711 US6160105A (en) 1998-10-13 1998-10-13 Monitoring toxicological responses
US09/172,108 1998-10-13
US09/141,825 1998-10-13
US09/172,711 1998-10-13

Publications (2)

Publication Number Publication Date
WO2000012760A2 WO2000012760A2 (fr) 2000-03-09
WO2000012760A3 true WO2000012760A3 (fr) 2000-08-03

Family

ID=27385714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/019768 WO2000012760A2 (fr) 1998-08-28 1999-08-27 Marqueurs de reaction toxicologique

Country Status (5)

Country Link
EP (1) EP1108067A2 (fr)
JP (1) JP2002523112A (fr)
AU (1) AU6022299A (fr)
CA (1) CA2340589A1 (fr)
WO (1) WO2000012760A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
AU2001280746A1 (en) 2000-07-21 2002-02-05 Phase-1 Molecular Toxicology Canine toxicity genes
AU2001280889A1 (en) * 2000-07-31 2002-02-13 Gene Logic, Inc. Molecular toxicology modeling
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
JP2004535776A (ja) * 2001-01-29 2004-12-02 フェイズ − 1 モレキュラー トクシコロジー、インコーポレイテッド ラット毒性関連遺伝子及びその使用
WO2002095000A2 (fr) 2001-05-22 2002-11-28 Gene Logic, Inc. Modelisation en toxicologie moleculaire
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
EP1413629A1 (fr) * 2001-08-03 2004-04-28 ASAHI MEDICAL Co., Ltd. Methode d'evaluation de la biocompatibilite
DE60236559D1 (de) * 2001-08-24 2010-07-08 Daikin Ind Ltd Verfahren zum Nachweis toxischer Substanzen
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
EP1344834A3 (fr) * 2002-03-14 2004-06-02 F. Hoffmann-La Roche Ag Méthodes pour la prédiction de la toxicité d'un composé
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
AU2003288649A1 (en) * 2002-12-31 2004-07-22 Pharmacia & Upjohn Company Llc Canine cyp1a2 sequences

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020681A1 (fr) * 1994-01-27 1995-08-03 Incyte Pharmaceuticals, Inc. Analyse comparative de produits de transcription geniques
WO1997013877A1 (fr) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Mesure de profils d'expression genique pour evaluer la toxicite

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020681A1 (fr) * 1994-01-27 1995-08-03 Incyte Pharmaceuticals, Inc. Analyse comparative de produits de transcription geniques
WO1997013877A1 (fr) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Mesure de profils d'expression genique pour evaluer la toxicite

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL embl heidelberg; 30 September 1995 (1995-09-30), LEE H.N. ET AL.,: "EST108960 rat PC-12 cells", XP002130308 *
LEE N.H. ET AL.,: "Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment", PROC. NATL. ACAD. SCI. USA, vol. 92, - August 1995 (1995-08-01), pages 8303 - 8307, XP002047703 *
SCHENA M ET AL: "PARALLEL HUMAN GENOME ANALYSIS: MICROARRAY-BASED EXPRESSION MONITORING OF 1000 GENES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 93, no. 20, 1 October 1996 (1996-10-01), pages 10614 - 10619, XP002912238, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
AU6022299A (en) 2000-03-21
WO2000012760A2 (fr) 2000-03-09
EP1108067A2 (fr) 2001-06-20
CA2340589A1 (fr) 2000-03-09
JP2002523112A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
WO2000012760A3 (fr) Marqueurs de reaction toxicologique
WO2001019800A3 (fr) Mediateurs de voies de signalisation hedgehog, preparations et utilisations associees
AU2003228649A1 (en) Compositions and methods related to two-arm nucleic acid probes
IL141567A0 (en) Fluorescence polarization in nucleic acid analysis
WO2007118144A3 (fr) Cartographie chromosomique à haute résolution
WO2003000863A3 (fr) Polynucleotides de defensine et methodes d'utilisation
AU2002255478A1 (en) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
CA2311182A1 (fr) Leurre du facteur de transcription et inhibiteur de la croissance tumorale
CA2412967A1 (fr) Procede de sequencement
WO2005044836A3 (fr) Composes nucleotidiques macromoleculaires et leurs procedes d'utilisation
EP1522853A4 (fr) Microreseau d'adn a sonde standard et kit contenant ce microreseau
WO1999067619A3 (fr) Composes et procedes pour la detection de biomolecules
IS8214A (is) 3,5 tvísetin indasól enfasambönd, lyfjasamsetningar, og aðferðir til að miðla eða hindra frumufjölgun
WO2003064625A3 (fr) Compositions oligonucleotidiques presentant une efficacite amelioree
AU2002239504A1 (en) Laboratory scale milling process
WO2003064605A3 (fr) Derives biologiques bruts capables d'une detection d'acide nucleique
ID26978A (id) Turunan-turunan asam aminometilkarboksilat
NO982176D0 (no) Korrosjonsinhiberte organiske syresammensetninger og fremgangsmÕter for anvendelse av disse
WO2002002740A3 (fr) Methodes et compositions pour determiner des fonctions geniques
Stenersen et al. Earthworms for toxicity testing; species differences in response towards cholinesterase inhibiting insecticides
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2004003220A3 (fr) Methodes et compositions permettant d'analyser des echantillons affaiblis, au moyen de panels de polymorphismes nucleotidiques uniques
AU3659199A (en) Methods for reducing non-specific binding to a nucleic acid probe array
EP1573037A3 (fr) Methodes et compositions permettant d'analyser des echantillons affaiblis, au moyen de panels de polymorphismes nucleotidiques uniques
AU4854999A (en) Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2340589

Country of ref document: CA

Ref country code: CA

Ref document number: 2340589

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 567743

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999968250

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999968250

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999968250

Country of ref document: EP